These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 23712335)
1. Ineffectiveness of pneumococcal vaccination in cardiovascular prevention: the CAPAMIS study. Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; de Diego C; Satue E; JAMA Intern Med; 2013 Nov; 173(20):1918-20. PubMed ID: 23712335 [No Abstract] [Full Text] [Related]
2. Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up. Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Gutierrez-Perez A; Vila-Rovira A; Gomez F; Raga X; de Diego C; Satue E; Salsench E; BMC Public Health; 2012 Mar; 12():222. PubMed ID: 22436146 [TBL] [Abstract][Full Text] [Related]
3. Rationale and design of the CAPAMIS study: effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke. Vila-Corcoles A; Hospital-Guardiola I; Ochoa-Gondar O; de Diego C; Salsench E; Raga X; Fuentes-Bellido CM BMC Public Health; 2010 Jan; 10():25. PubMed ID: 20085658 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study. Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; Gomez-Bertomeu F; Figuerola-Massana E; Raga-Luria X; Hospital-Guardiola I Clin Infect Dis; 2014 Apr; 58(7):909-17. PubMed ID: 24532544 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects. Vila-Córcoles A; Ochoa-Gondar O; Llor C; Hospital I; Rodríguez T; Gómez A Eur Respir J; 2005 Dec; 26(6):1086-91. PubMed ID: 16319340 [TBL] [Abstract][Full Text] [Related]
6. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Hung IF; Leung AY; Chu DW; Leung D; Cheung T; Chan CK; Lam CL; Liu SH; Chu CM; Ho PL; Chan S; Lam TH; Liang R; Yuen KY Clin Infect Dis; 2010 Nov; 51(9):1007-16. PubMed ID: 20887208 [TBL] [Abstract][Full Text] [Related]
7. Pneumococcal polysaccharide vaccine may not prevent hospitalization for pneumonia in elderly individuals. Skull SA; Andrews RM; Byrnes GB; Kelly HA; Nolan TM; Brown GV; Campbell DA Clin Infect Dis; 2007 Feb; 44(4):617; author reply 617-8. PubMed ID: 17260423 [No Abstract] [Full Text] [Related]
10. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness. Fedson DS Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925 [TBL] [Abstract][Full Text] [Related]
11. Aetiology of community-acquired pneumonia in hospitalized adult patients in New Caledonia. Mermond S; Berlioz-Arthaud A; Estivals M; Baumann F; Levenes H; Martin PM Trop Med Int Health; 2010 Dec; 15(12):1517-24. PubMed ID: 20955369 [TBL] [Abstract][Full Text] [Related]
12. Pneumococcal vaccination. Williams RM Lippincotts Prim Care Pract; 1998; 2(6):625-33. PubMed ID: 9883157 [TBL] [Abstract][Full Text] [Related]
13. The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007). Gil-Prieto R; García-García L; Alvaro-Meca A; Méndez C; García A; de Miguel AG Vaccine; 2011 Jan; 29(3):412-6. PubMed ID: 21111780 [TBL] [Abstract][Full Text] [Related]
14. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia. Johnstone J; Eurich DT; Minhas JK; Marrie TJ; Majumdar SR Clin Infect Dis; 2010 Jul; 51(1):15-22. PubMed ID: 20504233 [TBL] [Abstract][Full Text] [Related]
15. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness. Simberkoff MS Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926 [TBL] [Abstract][Full Text] [Related]
16. Pneumococcal vaccination and risk of myocardial infarction. Lamontagne F; Garant MP; Carvalho JC; Lanthier L; Smieja M; Pilon D CMAJ; 2008 Oct; 179(8):773-7. PubMed ID: 18838452 [TBL] [Abstract][Full Text] [Related]
17. Methodology of observational studies of pneumococcal polysaccharide vaccine. Vila Corcoles A; Ochoa Gondar O; Llor C Lancet Infect Dis; 2004 Feb; 4(2):71. PubMed ID: 14871627 [No Abstract] [Full Text] [Related]
18. Evaluating the clinical effectiveness of pneumococcal vaccination in preventing myocardial infarction: The CAPAMIS study, three-year follow-up. Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; de Diego-Cabanes C; Hospital-Guardiola I; Jariod-Pamies M; Vaccine; 2014 Jan; 32(2):252-7. PubMed ID: 24262314 [TBL] [Abstract][Full Text] [Related]